Long-term benefits like skin brightening and detoxification appear with consistent treatments
Recognized for its anti-aging, revitalizing and hair-growth stimulating effects
Short NJ, Garcia-Manero G, Naqvi K, Kornblau S, Takahashi K, Montalban-Bravo G, Khouri R, Andreeff M , Konopleva M, DiNardo CD, Alvarado Y, Ghosn M, Estrov Z, Bose P, Islam R, Dong X, Cortes JE, Kantarjian HM, Jabbour EJ
novonordisk.com/content/nncorp Top-Line Summary: REDEFINE 4 (CagriSema vs Tirzepatide) - - - CagriSema: 23.0% weight loss (efficacy estimand) Tirzepatide: 25.5% weight loss Treatment-regimen estimand: CagriSema 20.2% Tirzepatide 23.6% Primary endpoint: Not met (non-inferiority) Safety: Mostly GI AEs, consistent with class Perspective: A therapy producing ~23% weight loss is framed as missing. Thats how far obesity pharmacotherapy has progressed
MET409 being evaluated for the treatment of NASH by Metacrine Investigative Site lowers liver content of fat, but still induces differentiated pruritus and LDL-C profile
Real people respond to messages within 24 hours, the care team is polite and helpful, and doctor visits are scheduled every three months